Evaluation of the relaxant effect of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in isolated detrusor smooth muscle

European Journal of Pharmacology

Volumn 637, Issue 1-3, 2010, Pages 171-177

  Báu, Fernando R ^a   Mónica, Fabiola Z T ^a   Priviero, Fernanda B M ^a   Baldissera, Lineu ^a   de Nucci, Gilberto ^a   Antunes, Edson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

BAY 41 2272; Calcium channel; Cyclic GMP; Detrusor smooth muscle; Potassium channel

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINO 5 CYCLOPROPYL 2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL]PYRIMIDINE; 8 BROMO CYCLIC GMP; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; N(G) NITROARGININE METHYL ESTER; NITROPRUSSIDE SODIUM; SILDENAFIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG ANTAGONISM; ENZYME ACTIVATION; FORCE TRANSDUCER; MALE; MOUSE; MUSCLE FORCE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SMOOTH MUSCLE;

ANIMALS; CALCIUM CHANNELS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME ACTIVATORS; GUANYLATE CYCLASE; MALE; MICE; MICE, INBRED C57BL; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; POTASSIUM CHANNELS; PYRAZOLES; PYRIDINES; RABBITS; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 77953288656     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.008     Document Type: Article

References (28)

1. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., Van Kerrebroeck P., Victor A., Wein A. Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003, 61:37-49.
2. Adelstein R.S., Hathaway D.R. Role of calcium and cyclic adenosine 3':5' monophosphate in regulating smooth muscle contraction. Mechanisms of excitation-contraction coupling in smooth muscle. Am. J. Cardiol. 1979, 44:783-787.
3. Andersson K.E., Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol. Rev. 2004, 84:935-986.
4. Baracat J.S., Teixeira C.E., Okuyama C.E., Priviero F.B., Faro R., Antunes E., De Nucci G. Relaxing effects induced by the soluble guanylyl cyclase stimulator BAY 41-2272 in human and rabbit corpus cavernosum. Eur. J. Pharmacol. 2003, 477:163-169.
5. Becker E.M., Alonso-Alija C., Apeler H., Gerzer R., Minuth T., Pleiss U., Schmidt P., Schramm M., Schröder H., Schroeder W., Steinke W., Straub A., Stasch J.P. NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272. BMC Pharmacol. 2001, 1:13.
6. Bischoff E., Schramm M., Straub A., Feurer A., Stasch J.P. BAY 41-2272 a stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo. Urology 2003, 61:464-467.
7. Borges de Oliveira-Junior E., Thomazzi S.M., Rehder J., Antunes E., Condino-Neto A. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells. Eur. J. Pharmacol. 2007, 567:43-49.
8. Evgenov O.V., Pacher P., Schmidt P.M., Haskó G., Schmidt H.H., Stasch J.P. NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat. Rev. Drug Discov. 2006, 5:755-768.
9. Fujiwara M., Andersson K., Persson K. Nitric oxide-induced cGMP accumulation in the mouse bladder is not related to smooth muscle relaxation. Eur. J. Pharmacol. 2000, 401:241-250.
10. Gillespie J.I., Markerink-van Ittersum M., de Vente J. cGMP-generating cells in the bladder wall: identification of distinct networks of interstitial cells. BJU Int. 2004, 94:1114-1124.
11. Kalsi J.S., Rees R.W., Hobbs A.J., Royle M., Kell P.D., Ralph D.J., Moncada S., Cellek S. BAY41-2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro. J. Urol. 2003, 169:761-766.
12. 2+ release and entry during contraction elicited by norepinephrine in rat resistance arteries. Am. J. Physiol. 1999, 276:H300-H308.
13. Mónica F.Z., Bricola A.A., Báu F.R., Freitas L.L., Teixeira S.A., Muscará M.N., Abdalla F.M., Porto C.S., De Nucci G., Zanesco A., Antunes E. Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity. Br. J. Pharmacol. 2008, 153:1659-1668.
14. Mullershausen F., Russwurm M., Friebe A., Koesling D. Inhibition of phosphodiesterase type 5 by the activator of nitric oxide-sensitive guanylyl cyclase BAY 41-2272. Circulation 2004, 109:1711-1713.
15. Persson K., Andersson K.E. Nitric oxide and relaxation of pig lower urinary tract. Br. J. Pharmacol. 1992, 106:416-422.
16. Persson K., Igawa Y., Mattiasson A., Andersson K.E. Effects of inhibition of the L-arginine/nitric oxide pathway in the rat lower urinary tract in vivo and in vitro. Br. J. Pharmacol. 1992, 107:178-184.
17. Persson K., Pandita R.K., Aszòdi A., Ahmad M., Pfeifer A., Fässler R., Andersson K.E. Functional characteristics of urinary tract smooth muscles in mice lacking cGMP protein kinase type I. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:1112-1120.
18. Priviero F.B., Baracat J.S., Teixeira C.E., Claudino M.A., De Nucci G., Antunes E. Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator. Clin. Exp. Pharmacol. Physiol. 2005, 32:728-734.
19. Stasch J.P., Becker E.M., Alonso-Alija C., Apeler H., Dembowsky K., Feurer A., Gerzer R., Minuth T., Perzborn E., Pleiss U., Schröder H., Schroeder W., Stahl E., Steinke W., Straub A., Schramm M. NO-independent regulatory site on soluble guanylate cyclase. Nature 2001, 410:212-215.
20. Stasch J.P., Schmidt P., Alonso-Alija C., Apeler H., Dembowsky K., Haerter M., Heil M., Minuth T., Perzborn E., Pleiss U., Schramm M., Schroeder W., Schröder H., Stahl E., Steinke W., Wunder F. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br. J. Pharmacol. 2002, 136:773-783.
21. Teixeira C.E., Priviero F.B., Claudino M.A., Baracat J.S., De Nucci G., Webb R.C., Antunes E. Stimulation of soluble guanylyl cyclase by BAY 41-2272 relaxes anococcygeus muscle: interaction with nitric oxide. Eur. J. Pharmacol. 2006, 13:157-165.
22. Teixeira C.E., Priviero F.B., Todd J., Webb R.C. Vasorelaxing effect of BAY 41-2272 in rat basilar artery: involvement of cGMP-dependent and independent mechanisms. Hypertension 2006, 47:596-602.
23. Teixeira C.E., Priviero F.B., Webb R.C. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole]. J. Pharmacol. Exp. Ther. 2006, 317:258-266.
24. Theobald R.J. Differing effects of N(G)-monomethyl L-arginine and 7-nitroindazole on detrusor activity. Neurourol. Urodyn. 2003, 22:62-69.
25. Thomazzi S.M., Moreira J., De Nucci G., Antunes E. Inhibitory effects on human eosinophil chemotaxis in vitro by BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase. Biochem. Pharmacol. 2005, 69:875-882.
26. Toque H.A., Antunes E., Teixeira C.E., De Nucci G. Increased cyclic guanosine monophosphate synthesis and calcium entry blockade account for the relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in the rabbit penile urethra. Urology 2008, 72:711-715.
27. Toque H.A., Teixeira C.E., Priviero F.B.M., Morganti R.P., Antunes E., De Nucci G. Vardenafil, but not sildenafil or tadalafil, has calcium-channel blocking activity in rabbit isolated pulmonary artery and human washed platelets. Br. J. Pharmacol. 2008, 154:787-796.
28. Wein A.J., Rackley R.R. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J. Urol. 2006, 175:S5-S10.